Literature DB >> 1312474

Expression of the murine interleukin 6 receptor in hepatoma cells: the intracytoplasmic domain is not required for interleukin 6 signal transduction.

M T Fiorillo1, C Toniatti, J Van Snick, G Ciliberto.   

Abstract

This paper reports on cDNA coding for the 80-kDa murine IL6 receptor (mIL6R) that was cloned from a mouse liver cDNA library. Human hepatoma Hep3B cells transfected transiently or stably with an expression vector carrying the entire coding region for mIL6R become responsive to mouse IL6 (mIL6). We monitored response to the cytokine through the transcriptional activation of a co-transfected IL6-inducible human C-reactive protein (CRP) promoter; response to mIL6 is lost upon treatment of the cells with increasing amounts of a monoclonal antibody to mIL6R. mIL6R mutants have been generated in the carboxy-terminal portion of the molecule. Their functional analysis in hepatoma cells shows that the intracytoplasmic domain of the receptor is not absolutely essential to IL6 signal transduction (i.e. CRP promoter activation), but that the last 40 amino acids contribute to maximal IL6 response in these cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1312474     DOI: 10.1002/eji.1830220325

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  5 in total

1.  Engineering human interleukin-6 to obtain variants with strongly enhanced bioactivity.

Authors:  C Toniatti; A Cabibbo; E Sporena; A L Salvati; M Cerretani; S Serafini; A Lahm; R Cortese; G Ciliberto
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

2.  Construction and characterization of a replication-deficient adenovirus expressing rat-soluble interleukin-6 receptor.

Authors:  V Thibault; B Terlain; F L Graham; J Gauldie
Journal:  Mol Med       Date:  1997-08       Impact factor: 6.354

Review 3.  Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation?

Authors:  W L Biffl; E E Moore; F A Moore; V M Peterson
Journal:  Ann Surg       Date:  1996-11       Impact factor: 12.969

4.  The RhoU/Wrch1 Rho GTPase gene is a common transcriptional target of both the gp130/STAT3 and Wnt-1 pathways.

Authors:  Davide Schiavone; Sarah Dewilde; Francesco Vallania; James Turkson; Ferdinando Di Cunto; Valeria Poli
Journal:  Biochem J       Date:  2009-06-26       Impact factor: 3.857

5.  Generation of interleukin-6 receptor antagonists by molecular-modeling guided mutagenesis of residues important for gp130 activation.

Authors:  R Savino; A Lahm; A L Salvati; L Ciapponi; E Sporeno; S Altamura; G Paonessa; C Toniatti; G Ciliberto
Journal:  EMBO J       Date:  1994-03-15       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.